The error points to a big question for pharma as AI gains autonomy and high-profile failures sharpen safety concerns: What ...

Genetic medicines and more selective small molecules are finally pushing the field toward new mechanisms — and potentially ...

The Danish biotech sharpened its global vaccine ambitions by tapping Tarja Stenvall, a Big Pharma vet, to take the helm.

Basecamp Research just netted $140 million in a series C fundraising round that valued the company at $800 million, according ...

Nimbus Therapeutics’ head of R&D dishes on what’s next in AI-enabled drug discovery, years after Takeda completed its ...

As more psychedelic drugs move toward market, developers are testing how far patent protection can extend around familiar compounds.

A steady stream of M&A has continued to reshape the contract research organization universe. As a case in point, the CRO Fortrea announced plans earlier this month to acquire Worldwide Clinical Trials ...